Disruptions, whether positive, like the addition of new data sources, or challenging, such as supplier exits, are part of the natural evolution of open claims. Specific changes, such as expanded ...

The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...

AI drives decision inputs: In 2025, both big pharma and small pharma use advanced predictive modeling, digital twins, and AI-powered analytics throughout R&D and regulatory processes. This reduces ...

Strengthen information governance with clear policies for data classification, retention, and legal holds to meet industry regulations and ensure defensibility. Embed compliance and collaboration ...

Market opportunities arise from the growing need for modernization and compliance assurance in FDA-regulated industries focusing on data integrity. Emphasizing cloud computing, automation, and mobile ...

The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.

Amit Singh is a global leader specializing in transformative AI and Master Data Management solutions. Please reach out to him on LinkedIn. In the highly regulated pharmaceutical industry, companies ...

Life sciences industry has regulatory compliance at the center of all its operations, so maintaining the integrity of data has always been a pressing need for this industry globally. Regulators such ...

DUBLIN--(BUSINESS WIRE)--The "Efficient Batch Record Design and Review" training has been added to ResearchAndMarkets.com's offering. This online training is designed for professionals in the ...

Pharma’s finally catching up: real-time data is helping teams move faster, stay compliant and deliver better care where it counts. In the rapidly evolving pharmaceutical and healthcare landscape, ...

aTyr Pharma's pivotal data readouts in 2025 for SSc-ILD (Phase 2) and pulmonary sarcoidosis (Phase 3) could significantly impact its market potential and approval prospects. Efzofitimod shows promise ...

The Trump administration wants countries that receive U.S. health aid to share data with Washington about pathogens that ...